These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 60623)

  • 1. Correction of abnormal coagulation in chronic liver disease by combined use of fresh-frozen plasma and prothrombin complex concentrates.
    Mannucci PM; Franchi F; Dioguardi N
    Lancet; 1976 Sep; 2(7985):542-5. PubMed ID: 60623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of factor-VII-rich prothrombin complex concentrate in liver disease.
    Green G; Dymock IW; Poller L; Thomson JM
    Lancet; 1975 Jun; 1(7920):1311-4. PubMed ID: 49516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Substitution therapy with prothrombin complex concentrates in acquired coagulation disorders].
    Fischer M
    Wien Klin Wochenschr; 1983 Feb; 95(3):82-5. PubMed ID: 6858171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of fresh frozen plasma or a concentrate of factor IX as replacement therapy before liver biopsy.
    Gazzard BG; Henderson JM; Williams R
    Gut; 1975 Aug; 16(8):621-5. PubMed ID: 1102399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Fresh-Frozen Plasma, Four-Factor Prothrombin Complex Concentrates, and Recombinant Factor VIIa to Facilitate Procedures in Critically Ill Patients with Coagulopathy from Liver Disease: A Retrospective Cohort Study.
    Kwon JO; MacLaren R
    Pharmacotherapy; 2016 Oct; 36(10):1047-1054. PubMed ID: 27547916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coagulation factor concentrate in the treatment of the haemorrhagic diathesis of fulminant hepatic failure.
    Gazzard BG; Lewis ML; Ash G; Rizza CR; Bidwell E; Williams R
    Gut; 1974 Dec; 15(12):993-8. PubMed ID: 4448416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute coagulopathy following infusion of prothrombin complex concentrate.
    Davey RJ; Shashaty GG; Rath CE
    Am J Med; 1976 May; 60(5):719-22. PubMed ID: 1020759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of hemostasis disorders in liver diseases:prothrombin-complex concentrates].
    Fischer M
    Z Gastroenterol; 1976 Oct; 14(6):650-3. PubMed ID: 997699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prothrombin complex concentrate: use in controlling the hemorrhagic diathesis of chronic liver disease.
    Bick RL; Schmalhorst WR; Shanbrom E
    Am J Dig Dis; 1975 Aug; 20(8):741-9. PubMed ID: 1080355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fresh frozen plasma--opinion and evidence.
    McClelland DB
    Transfus Med; 1992 Jun; 2(2):97-8. PubMed ID: 1308212
    [No Abstract]   [Full Text] [Related]  

  • 11. First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study.
    Görlinger K; Dirkmann D; Hanke AA; Kamler M; Kottenberg E; Thielmann M; Jakob H; Peters J
    Anesthesiology; 2011 Dec; 115(6):1179-91. PubMed ID: 21970887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Management of hemostasis abnormalities in patients with liver failure].
    Ozier Y; Cadic A; Dovergne A
    Transfus Clin Biol; 2013 May; 20(2):249-54. PubMed ID: 23523600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coagulation factors in chronic liver disease.
    Donaldson GW; Davies SH; Darg A; Richmond J
    J Clin Pathol; 1969 Mar; 22(2):199-204. PubMed ID: 5776551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Summary of work session 1: Blood coagulation in gastroenterology].
    Bredden K; Lechner K
    Z Gastroenterol; 1976 Mar; 14 Suppl():202-10. PubMed ID: 785839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Letter: Prothrombin-complex concentrates in liver disease.
    Lancet; 1975 Jul; 2(7926):188-9. PubMed ID: 49788
    [No Abstract]   [Full Text] [Related]  

  • 16. Indications for prothrombin complex concentrates in massive transfusions.
    Blauhut B
    Thromb Res; 1999 Aug; 95(4 Suppl 1):S63-9. PubMed ID: 10499911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The liver and blood coagulation: physiology and pathology.
    Roberts HR; Cederbaum AI
    Gastroenterology; 1972 Aug; 63(2):297-320. PubMed ID: 4558715
    [No Abstract]   [Full Text] [Related]  

  • 18. Prothrombin, alone or in complex concentrates or plasma, reduces bleeding in a mouse model of blood exchange-induced coagulopathy.
    Eltringham-Smith LJ; Yu R; Qadri SM; Wang Y; Bhakta V; Pryzdial EL; Crosby JR; Ni H; Sheffield WP
    Sci Rep; 2019 Sep; 9(1):13029. PubMed ID: 31506556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of a prothrombin complex concentrate with two virus-inactivation steps in patients with severe liver damage.
    Lorenz R; Kienast J; Otto U; Egger K; Kiehl M; Schreiter D; Kwasny H; Haertel S; Barthels M
    Eur J Gastroenterol Hepatol; 2003 Jan; 15(1):15-20. PubMed ID: 12544689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired coagulopathy owing to parenteral cefamandole: renal failure as a predisposing factor.
    Chang JC
    Ann Clin Lab Sci; 1983; 13(5):418-24. PubMed ID: 6638932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.